These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 32460855)

  • 21. Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change.
    Soldan A; Pettigrew C; Cai Q; Wang MC; Moghekar AR; O'Brien RJ; Selnes OA; Albert MS;
    JAMA Neurol; 2016 Jun; 73(6):698-705. PubMed ID: 27064267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a smartphone screening test for preclinical Alzheimer's disease and validation across the dementia continuum.
    Alty J; Goldberg LR; Roccati E; Lawler K; Bai Q; Huang G; Bindoff AD; Li R; Wang X; St George RJ; Rudd K; Bartlett L; Collins JM; Aiyede M; Fernando N; Bhagwat A; Giffard J; Salmon K; McDonald S; King AE; Vickers JC
    BMC Neurol; 2024 Apr; 24(1):127. PubMed ID: 38627686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a straightforward and sensitive scale for MCI and early AD clinical trials.
    Huang Y; Ito K; Billing CB; Anziano RJ;
    Alzheimers Dement; 2015 Apr; 11(4):404-14. PubMed ID: 25022537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study.
    Vos SJ; Xiong C; Visser PJ; Jasielec MS; Hassenstab J; Grant EA; Cairns NJ; Morris JC; Holtzman DM; Fagan AM
    Lancet Neurol; 2013 Oct; 12(10):957-65. PubMed ID: 24012374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment.
    Cloutier S; Chertkow H; Kergoat MJ; Gauthier S; Belleville S
    J Alzheimers Dis; 2015; 47(4):901-13. PubMed ID: 26401770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
    Crane PK; Carle A; Gibbons LE; Insel P; Mackin RS; Gross A; Jones RN; Mukherjee S; Curtis SM; Harvey D; Weiner M; Mungas D;
    Brain Imaging Behav; 2012 Dec; 6(4):502-16. PubMed ID: 22782295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a novel cognitive composite outcome to assess therapeutic effects of exercise in the EXERT trial for adults with MCI: The ADAS-Cog-Exec.
    Jacobs DM; Thomas RG; Salmon DP; Jin S; Feldman HH; Cotman CW; Baker LD; ;
    Alzheimers Dement (N Y); 2020; 6(1):e12059. PubMed ID: 32995469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition.
    Riley KP; Jicha GA; Davis D; Abner EL; Cooper GE; Stiles N; Smith CD; Kryscio RJ; Nelson PT; Van Eldik LJ; Schmitt FA
    J Alzheimers Dis; 2011; 25(4):707-17. PubMed ID: 21498903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.
    Donohue MC; Sperling RA; Salmon DP; Rentz DM; Raman R; Thomas RG; Weiner M; Aisen PS; ; ;
    JAMA Neurol; 2014 Aug; 71(8):961-70. PubMed ID: 24886908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer's dementia.
    Xiong LY; Ouk M; Wu CY; Rabin JS; Lanctôt KL; Herrmann N; Black SE; Edwards JD; Swardfager W
    Alzheimers Res Ther; 2021 Sep; 13(1):147. PubMed ID: 34479635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting progression to Alzheimer's disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests.
    De Simone MS; Perri R; Fadda L; Caltagirone C; Carlesimo GA
    J Neurol; 2019 Jan; 266(1):102-111. PubMed ID: 30386876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease.
    Lopez Lopez C; Tariot PN; Caputo A; Langbaum JB; Liu F; Riviere ME; Langlois C; Rouzade-Dominguez ML; Zalesak M; Hendrix S; Thomas RG; Viglietta V; Lenz R; Ryan JM; Graf A; Reiman EM
    Alzheimers Dement (N Y); 2019; 5():216-227. PubMed ID: 31211217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modelling Decline in Cognition to Decline in Function in Alzheimer's Disease.
    Karcher H; Savelieva M; Qi L; Hummel N; Caputo A; Risson V; Capkun G; Alzheimer's Disease Neuroimaging Initiative
    Curr Alzheimer Res; 2020; 17(7):635-657. PubMed ID: 33032508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score.
    Lim YY; Snyder PJ; Pietrzak RH; Ukiqi A; Villemagne VL; Ames D; Salvado O; Bourgeat P; Martins RN; Masters CL; Rowe CC; Maruff P
    Alzheimers Dement (Amst); 2016; 2():19-26. PubMed ID: 27239532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years.
    Walter S; Langford OG; Clanton TB; Jimenez-Maggiora GA; Raman R; Rafii MS; Shaffer EJ; Sperling RA; Cummings JL; Aisen PS
    J Prev Alzheimers Dis; 2020; 7(4):234-241. PubMed ID: 32920625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Neighborhood Context, Cognitive Decline, and Cortical Change in an Unimpaired Cohort.
    Hunt JFV; Vogt NM; Jonaitis EM; Buckingham WR; Koscik RL; Zuelsdorff M; Clark LR; Gleason CE; Yu M; Okonkwo O; Johnson SC; Asthana S; Bendlin BB; Kind AJH
    Neurology; 2021 May; 96(20):e2500-e2512. PubMed ID: 33853894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.